Bruce G Pollock Selected Research

Citalopram

10/2019	Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
5/2016	Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study.
5/2016	Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial.
3/2016	Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
3/2016	Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease.
2/2016	A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.
1/2016	Principal components analysis of agitation outcomes in Alzheimer's disease.
1/2016	The Effect of Intravenous Citalopram on the Neural Substrates of Obsessive-Compulsive Disorder.
1/2016	R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
12/2015	Change in agitation in Alzheimer's disease in the placebo arm of a nine-week controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bruce G Pollock Research Topics

Disease

39	Schizophrenia (Dementia Praecox) 01/2022 - 11/2002
27	Dementia (Dementias) 04/2022 - 03/2002
27	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2004
26	Cognitive Dysfunction 04/2022 - 03/2003
14	Major Depressive Disorder (Major Depressive Disorders) 12/2021 - 01/2003
12	Psychotic Disorders (Schizoaffective Disorder) 01/2021 - 03/2002
7	Mental Disorders (Mental Disorder) 01/2021 - 12/2008
6	Anxiety Disorders (Anxiety Disorder) 03/2013 - 12/2003
4	Stroke (Strokes) 05/2017 - 01/2008
4	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 01/2011
4	Delirium 09/2011 - 01/2002
4	Mood Disorders (Mood Disorder) 07/2010 - 03/2003
4	Hepatitis C 07/2010 - 01/2004
3	Hallucinations (Hallucination) 01/2019 - 03/2002
3	Body Weight (Weight, Body) 02/2016 - 08/2007
3	Sleep Deprivation 01/2009 - 09/2002
3	Hypertension (High Blood Pressure) 07/2008 - 02/2006
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2021
2	COVID-19 01/2021 - 01/2020
2	Amyloid Plaque 11/2019 - 01/2007
2	Mixed Dementias 01/2018 - 12/2004
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2018 - 12/2004
2	Agnosia (Visual Agnosia) 11/2017 - 09/2011
2	Hyperprolactinemia 12/2016 - 08/2013
2	Treatment-Resistant Schizophrenia 08/2014 - 09/2011
2	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2011 - 09/2006
2	Fatigue 07/2010 - 01/2009
2	Psychomotor Agitation (Akathisia) 02/2009 - 02/2007
2	Heart Diseases (Heart Disease) 07/2008 - 03/2006
2	Vascular Diseases (Vascular Disease) 08/2007 - 06/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2007 - 02/2006
2	Depressive Disorder (Melancholia) 04/2007 - 11/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2004 - 02/2004
2	Hyponatremia 02/2004 - 09/2003
1	Tobacco Use Disorder (Nicotine Dependence) 01/2022
1	Brain Diseases (Brain Disorder) 12/2021
1	Memory Disorders (Memory Loss) 11/2017
1	Amyloid angiopathy 04/2016
1	Cerebral Infarction 04/2016

Drug/Important Bio-Agent (IBA)

23	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 03/2002
23	Citalopram FDA LinkGeneric 10/2019 - 03/2002
22	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022 - 12/2004
11	Olanzapine (Zyprexa)FDA Link 01/2022 - 12/2004
11	Cholinergic Antagonists (Anticholinergics)IBA 12/2021 - 12/2004
11	Antidepressive Agents (Antidepressants)IBA 11/2016 - 09/2002
11	Paroxetine (Paxil)FDA LinkGeneric 01/2009 - 01/2002
9	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016 - 03/2002
8	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2022 - 12/2009
8	Pharmaceutical PreparationsIBA 01/2018 - 11/2002
8	Dopamine (Intropin)FDA LinkGeneric 12/2016 - 04/2009
6	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 06/2009
6	Escitalopram FDA Link 11/2019 - 01/2009
5	Cholinergic Agents (Cholinergics)IBA 01/2021 - 09/2011
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2014 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2010
4	Amyloid (Amyloid Fibrils)IBA 11/2019 - 01/2016
4	ProlactinIBA 09/2015 - 02/2006
3	ApolipoproteinsIBA 01/2021 - 06/2004
3	norclozapineIBA 01/2021 - 01/2012
3	Biological ProductsIBA 01/2021 - 08/2005
3	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 09/2002
3	BenzodiazepinesIBA 11/2016 - 12/2003
3	RacloprideIBA 10/2014 - 04/2009
3	Memantine (Namenda)FDA Link 03/2013 - 01/2011
3	Interferon-alpha (Interferon Alfa)IBA 07/2010 - 02/2009
3	Serotonin (5 Hydroxytryptamine)IBA 12/2008 - 02/2004
2	Apolipoproteins E (ApoE)IBA 01/2021 - 06/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 01/2019
2	Inosine Monophosphate (IMP)IBA 04/2019 - 05/2017
2	ziprasidone (Geodon)FDA Link 03/2014 - 11/2011
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2011 - 01/2008
2	Perphenazine (Trilafon)FDA LinkGeneric 01/2010 - 03/2002
2	LipidsIBA 07/2008 - 02/2006
2	Nortriptyline (Aventyl)FDA LinkGeneric 02/2007 - 03/2003
2	SodiumIBA 02/2004 - 09/2003
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 04/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Nicotine FDA Link 01/2022
1	hydroxide ionIBA 01/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2021
1	VaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2019
1	Fluorine-18IBA 11/2017
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 05/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2016
1	Therapeutic UsesIBA 05/2016
1	Lorazepam (Ativan)FDA LinkGeneric 05/2016
1	Staphylococcal Protein A (Protein A)IBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 04/2016

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2016 - 03/2002
6	Transcranial Direct Current Stimulation 01/2022 - 01/2019
5	Therapeutics 11/2009 - 01/2004
4	Long-Term Care 01/2022 - 12/2006
3	Drug Tapering 10/2016 - 10/2014
2	Transcranial Magnetic Stimulation 11/2021 - 09/2011
2	Activities of Daily Living (ADL) 01/2020 - 11/2017
1	Polypharmacy 11/2017